How Poor Gut Health Affects Female Hormones, Cycles, and Fertility

Women's Journal Staff on April 25, 2026

By: Madison Ordway, FDN-P

If you’ve been dealing with painful or irregular periods, worsening PMS, hormonal acne, unexplained infertility, or cycle irregularities, and your bloodwork keeps coming back “normal,” there is an area that conventional medicine doesn’t always investigate in depth: your gut.

As a Functional Diagnostic Nutrition Practitioner who works with comprehensive stool analysis as part of client assessments, I often find the gut-hormone connection to be a meaningful clinical relationship. Many women exploring their hormonal health and fertility benefit from considering gut function alongside traditional hormone evaluations.

Why the Gut and Female Hormones Are Connected

Most women are taught to think about their hormones and their digestion as separate systems. The reality is that they are in constant, bidirectional communication, and what happens in the gut can shape what happens with estrogen, progesterone, testosterone, and the entire hormonal signaling cascade.

The gut microbiome participates in producing certain hormones, regulating hormone receptors, metabolizing and clearing spent hormones, and modulating the inflammation that influences how hormones are made and used. When the gut is healthy and balanced, this process tends to run efficiently. When it is dysregulated, through dysbiosis, pathogen overgrowth, or a compromised gut lining, the hormonal effects can be wide-reaching.

How the Estrobolome Regulates Estrogen Metabolism

One of the important gut-hormone mechanisms is the estrobolome, a specific collection of gut bacteria that produces an enzyme called beta-glucuronidase. Here is how it works in practice.

After your body uses estrogen, the liver packages it up (a process called conjugation) to prepare it for safe excretion through the digestive tract. Under normal conditions, this conjugated estrogen moves through the gut and leaves the body in stool. When beta-glucuronidase is elevated, which happens when certain bacteria overgrow, this enzyme can break open that conjugation and release the estrogen back into the gut, where it is reabsorbed into the bloodstream and re-enters circulation.

This effectively recycles estrogen your body had already processed. Over time, this pattern is associated with a state often called estrogen dominance, a relative excess of estrogen compared to progesterone. Commonly reported symptoms include:

Heavy, painful, or clotted periods
Severe PMS, such as mood swings, crying spells, rage, or anxiety in the luteal phase
Hormonal acne, particularly along the jawline and chin
Breast tenderness or fibrocystic changes
Bloating that worsens in the week before your period
Difficulty losing weight, especially around the hips and thighs
Fatigue and disrupted sleep in the luteal phase

What makes this mechanism notable is that a beta-glucuronidase imbalance may be overlooked in women whose serum hormone labs look within normal range. The area being examined is not the production of estrogen but the process of clearing it.

The Role of Gut Dysbiosis, Inflammation, and the HPA Axis

Gut dysbiosis, an imbalance in the microbial ecosystem, can drive chronic, low-grade inflammation throughout the body. Inflammation has been shown to influence the hypothalamic-pituitary-adrenal (HPA) axis, which governs the communication chain between the brain and the adrenal glands. When the HPA axis is affected by gut-driven inflammation, cortisol patterns can shift, and elevated cortisol may compete with progesterone production at the precursor molecule pregnenolone. This is sometimes called the “pregnenolone steal.”

The result can be a deepening of estrogen-progesterone imbalance, with potential effects on adrenal function, sleep, and cycle regularity. Secretory IgA (SIgA), the gut’s primary immune marker, often reflects the degree of immune and stress load the body is carrying. Lower SIgA is frequently observed in women dealing with both chronic gut issues and HPA axis patterns.

Intestinal Permeability, Immune Activation, and Hormonal Patterns

Another important gut-hormone area is intestinal permeability, commonly referred to as leaky gut. When the tight junctions of the gut lining are compromised, particles that should remain inside the gut can cross into the bloodstream and trigger a systemic immune response. A protein called Zonulin regulates those tight junctions and is used as a marker of gut barrier integrity in comprehensive stool analysis.

Lipopolysaccharides (LPS), inflammatory molecules shed by gram-negative bacteria, are among the particles that may cross a permeable gut wall. Once in the bloodstream, research has examined how LPS can influence hormone receptor sensitivity, particularly at the thyroid and ovarian level. Women with gut barrier patterns and LPS exposure sometimes experience fatigue, irregular cycles, anovulation, and skin inflammation, reflecting the interconnection between gut, immune, and hormonal systems.

The Gut-Fertility Research Landscape

The relationship between gut health and fertility is an area of growing research. Current literature explores how chronic gut dysbiosis, inflammation, and estrogen clearance patterns may influence the reproductive environment. Some of the connections being studied include:

Beta-glucuronidase patterns and estrogen recirculation, and how these may relate to the estrogen-progesterone ratio involved in ovulation timing and luteal phase
Gut-driven inflammation and its potential effect on ovarian function, as inflammatory cytokines are of interest in fertility research
Intestinal permeability and LPS exposure, which have been examined in research on endometriosis, a condition where immune dysregulation is increasingly studied
Digestive function and nutrient absorption, particularly folate, B12, zinc, and fat-soluble vitamins, which are foundational nutrients during the preconception period
Lactobacillus balance in the gut and its potential relationship to the vaginal microbiome, which research has examined in the context of implantation and early pregnancy

Women exploring their fertility often consider gut health as part of a broader wellness picture, alongside traditional reproductive evaluations.

What Comprehensive Stool Analysis Looks At

A standard hormone panel reflects what is circulating in the blood at a given moment. It does not always reflect why those levels are what they are, what is affecting hormone metabolism downstream, or what is influencing the inflammation that shapes the hormonal environment. Comprehensive stool analysis examines gut-level areas such as beta-glucuronidase, Zonulin, Secretory IgA, dysbiosis patterns, pathogen presence, and digestive function, areas that standard blood panels are not designed to capture.

When working with women whose hormonal symptoms have not resolved through conventional approaches, incorporating a comprehensive look at the gut can be a valuable part of the overall picture.

Exploring Your Gut Health

If you are a woman dealing with hormonal symptoms, cycle irregularities, or fertility questions and have not looked closely at your gut health, GI-MAP testing is one comprehensive stool analysis option to consider. The at-home kit ships across the United States and Canada. Your hormones and your gut are connected, and looking at both can offer a more complete picture.

About the Author

Madison Ordway, FDN-P is a Functional Diagnostic Nutrition Practitioner who has spent years working with clients across North America on their health and wellness journeys. She focuses on gut health, hormone balance, and mineral optimization, and incorporates comprehensive stool analysis into her client work. Madison is passionate about making functional testing accessible.

Disclaimer: The information provided in this article is for educational purposes only and is not intended to constitute medical advice, diagnosis, or treatment. Nothing in this article should be interpreted as a substitute for professional medical advice. Always consult with a qualified healthcare provider or physician before making any changes to your diet, supplement regimen, or health protocol. The GI-MAP test is a clinical tool and results should be interpreted in the context of your full health history by a qualified practitioner. Individual results may vary. Madison Ordway is not affiliated with Diagnostic Solutions Laboratory.

Lululemon Names Nike Veteran Heidi O’Neill as CEO

Womens Journal Staff 2 on April 25, 2026

Lululemon has appointed longtime Nike executive Heidi O’Neill as its next chief executive officer, bringing in a leader with nearly three decades of experience in global consumer brand strategy, product leadership, and women’s division management. The appointment places O’Neill at the helm of the athletic apparel company during a planned leadership transition that includes her joining the company’s board of directors.

O’Neill most recently held the role of president of consumer, product, and brand at Nike, where she oversaw global initiatives spanning product development, brand strategy, and consumer engagement. Her tenure at Nike lasted 27 years, during which she advanced through multiple senior leadership positions across product and divisional operations.

Her appointment at Lululemon comes with an effective start date of September 8, 2026, providing a defined transition period before she assumes full executive responsibilities. She will be based in Vancouver and is expected to take on both CEO duties and board membership upon joining the company.

The leadership change reflects Lululemon’s structured approach to executive succession, aligning long-term strategic planning with senior leadership continuity. O’Neill succeeds the outgoing leadership framework as the company continues to operate in the global premium athletic apparel sector.

Executive Career Spanning Nike’s Global Consumer Strategy

Heidi O’Neill’s career at Nike is defined by extensive leadership across product innovation, brand development, and global consumer strategy. Early in her tenure, she held roles focused on product categories and market development, contributing to Nike’s expansion across multiple consumer segments.

One of her most significant leadership assignments was overseeing Nike’s global women’s division, a role she held for seven years. In this position, she managed strategy and operations for women’s athletic and lifestyle products across international markets. The division played a key role in Nike’s broader business structure, particularly as demand for women’s performance apparel expanded globally.

Her responsibilities included aligning product development with consumer demand, guiding marketing strategy, and managing cross-regional execution. This role positioned her at the center of Nike’s efforts to strengthen its presence in women’s sportswear and lifestyle categories.

Following her leadership in the women’s division, O’Neill transitioned into a broader executive role as president of consumer, product, and brand. In this position, she oversaw integrated functions spanning product creation, global branding, and consumer engagement strategies across Nike’s worldwide operations.

This executive role required coordination between design teams, marketing divisions, and regional markets, ensuring consistency in brand positioning and product delivery. Her work contributed to shaping Nike’s global consumer strategy during a period of significant expansion in digital commerce and lifestyle-oriented apparel markets.

Transition to Lululemon Leadership and Board Appointment

O’Neill’s move to Lululemon represents a shift from senior executive leadership within a global sportswear corporation to chief executive responsibility at a publicly traded company with a strong focus on premium athletic apparel. Her appointment reflects Lululemon’s emphasis on leadership experience in global consumer markets and product-driven brand development.

Alongside her CEO appointment, O’Neill will also join Lululemon’s board of directors. This dual role integrates executive leadership with governance oversight, a structure commonly used in publicly listed companies to align strategic decision-making with board-level direction.

Her departure from Nike in May 2025 concluded a 27-year tenure that spanned multiple phases of the company’s growth, including expansion into global markets, diversification of product categories, and increased focus on women-centered athletic wear.

At Lululemon, her leadership is expected to focus on managing global operations while maintaining the company’s positioning in the premium performance and lifestyle apparel segment. The defined transition timeline allows for structured leadership handover and operational continuity ahead of her start date.

Board Experience Across Consumer-Facing Industries

In addition to her executive background, O’Neill brings governance experience through board roles in several major companies. She currently serves on the boards of Spotify Technology and Hyatt Hotels, contributing to oversight and strategic planning across digital media and hospitality sectors.

Her board experience extends her professional exposure beyond the apparel industry, providing insight into consumer behavior across entertainment, travel, and lifestyle services. This cross-sector involvement is a common feature among senior executives in global consumer industries, where brand strategy increasingly intersects with digital platforms and service-based ecosystems.

Board service responsibilities typically include evaluating corporate strategy, financial performance, and executive oversight. O’Neill’s participation in these roles adds a governance dimension to her leadership profile, complementing her operational experience in large-scale consumer organizations.

Her combined background in executive leadership and board governance positions her within a broader category of senior executives with multi-industry exposure, particularly in consumer-driven markets.

Leadership Transition Structure and Corporate Direction

The appointment of a new chief executive at Lululemon reflects a planned leadership transition designed to ensure continuity across global operations. The company has established a future start date for O’Neill’s tenure, allowing time for organizational alignment and executive transition processes.

Executive Chair Marti Morfitt described O’Neill as a leader with extensive experience in consumer-driven brand strategy and large-scale execution. Her background in managing global product and brand systems was highlighted as a key factor in her selection.

The transition also reflects broader patterns in the consumer apparel industry, where leadership appointments increasingly prioritize executives with global operational experience and cross-functional expertise in product, branding, and consumer engagement.

O’Neill’s role will involve oversight of Lululemon’s global business operations, with responsibility for aligning product strategy, brand positioning, and organizational execution across international markets. Her appointment marks a structured leadership shift within the company’s governance framework, integrating executive leadership with board participation as part of its long-term strategic direction.